2024 surveillance of familial hypercholesterolaemia (NICE guideline CG71)

Prioritisation board agreed there was sufficient evidence to support recommendation development. Updated guidance should improve patient outcomes.

Review decision: Prioritised

We plan to update the recommendations on case finding and diagnosis.

 

This page was last updated: